|

Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies

RECRUITINGN/ASponsored by Miltenyi Biomedicine GmbH
Actively Recruiting
PhaseN/A
SponsorMiltenyi Biomedicine GmbH
Started2024-05-05
Est. completion2040-12-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06508775

Summary

The goal of this Long-Term Follow-Up Trial is to assess long-term safety and efficacy of Miltenyi CAR T treatment.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patient underwent treatment with a Miltenyi CAR T cell therapy in one of the parent trials at least 12 months prior to enrollment in long-term follow-up.
* Patient has provided informed consent prior to enrollment.

Exclusion Criteria:

* No exclusion criteria

Conditions8

Acute Lymphatic LeukemiaB-Cell Non-Hodgkin LymphomaCancerChildhood Non-Hodgkin LymphomaChronic Lymphatic LeukemiaMelanoma Stage IIIMelanoma Stage IVPediatric ALL

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.